Fareva La Vallee
France Updated 9 July 2026
Fareva La Vallee is an API manufacturer based in France. It holds one active US drug master file and one valid CEP. Its GMP standing is certified by ANSM (FR) and US FDA. Its most recent recorded inspection, by US FDA, closed on 6 October 2023 as VAI.
4
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 6 October 2023 VAI US FDA
- 1 June 2018 VAI US FDA
- 15 May 2014 NAI US FDA
- 27 May 2011 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| SAINT GERMAIN LAPRADE, France | Not on file |
| France, France | 3003121602 |
| Saint-Germain-Laprade, France | Not on file |
| St Germain Laprade, France | Not on file |
What they file, and where
| Molecule | Regulators | Docs |
| Timolol | EDQM, US FDA | 2 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| ANSM (FR) | None | 10 |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Fareva La Vallee comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 6 October 2023.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates